{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:33:42Z","timestamp":1786984422776,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:00:00Z","timestamp":1760918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["xtr062023003"],"award-info":[{"award-number":["xtr062023003"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["188"],"award-info":[{"award-number":["188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,473,291"],"award-info":[{"award-number":["82,473,291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,170,626"],"award-info":[{"award-number":["82,170,626"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82,403,188"],"award-info":[{"award-number":["82,403,188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aohep.2025.102144","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:30:32Z","timestamp":1761363032000},"page":"102144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Trends and health inequalities of hepatitis virus-associated liver cancer mortality during 1990\u20132050"],"prefix":"10.1016","volume":"31","author":[{"given":"Yujiao","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyue","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3633-0725","authenticated-orcid":false,"given":"Jian","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanpeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Bo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrui","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1463-8035","authenticated-orcid":false,"given":"Fanpu","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.aohep.2025.102144_bib0001","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102144_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.aohep.2025.102144_bib0003","doi-asserted-by":"crossref","first-page":"81","DOI":"10.62476\/abes9s81","article-title":"Novel nanomaterials for hepatobiliary diseases treatment and future perspectives","volume":"9","author":"Huseynov","year":"2024","journal-title":"Adv Biol Earth Sci"},{"issue":"11","key":"10.1016\/j.aohep.2025.102144_bib0004","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s11094-018-1724-6","article-title":"The effects of cimetidine, N-acetylcysteine, and taurine on thioridazine metabolic activation and induction of oxidative stress in isolated rat hepatocytes","volume":"51","author":"Eftekhari","year":"2018","journal-title":"Pharm Chem J"},{"issue":"3","key":"10.1016\/j.aohep.2025.102144_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.103910","article-title":"NAFLD and NASH: etiology, targets and emerging therapies","volume":"29","author":"Wei","year":"2024","journal-title":"Drug Discov Today"},{"issue":"8","key":"10.1016\/j.aohep.2025.102144_bib0006","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102144_bib0007","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.aohep.2025.102144_bib0008","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.3390\/cancers15082388","article-title":"A historical overview on the role of Hepatitis B and C viruses as aetiological factors for hepatocellular carcinoma","volume":"15","author":"Stroffolini","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.aohep.2025.102144_bib0009","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1159\/000508568","article-title":"The burden and trends of primary liver cancer caused by specific etiologies from 1990 to 2017 at the global, regional, national, age, and sex level results from the Global Burden of Disease Study 2017","volume":"9","author":"Lin","year":"2020","journal-title":"Liver Cancer"},{"issue":"7","key":"10.1016\/j.aohep.2025.102144_bib0010","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2468-1253(19)30119-0","article-title":"A global scientific strategy to cure hepatitis B","volume":"4","author":"Revill","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102144_bib0011","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","article-title":"Global epidemiology and genotype distribution of the hepatitis C virus infection","volume":"61","author":"Gower","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.102144_bib0012","series-title":"Current trends and concerns in infectious diseases","first-page":"103","article-title":"Major advances in Hepatitis C treatment but not Hepatitis B","author":"Fong","year":"2020"},{"issue":"7","key":"10.1016\/j.aohep.2025.102144_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jiph.2024.04.027","article-title":"Global mortality of chronic liver diseases attributable to Hepatitis B virus and Hepatitis C virus infections from 1990 to 2019 and projections to 2030","volume":"17","author":"Ou","year":"2024","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.aohep.2025.102144_bib0014","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s41256-025-00416-y","article-title":"The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"Liu","year":"2025","journal-title":"Glob Health Res Policy"},{"issue":"12","key":"10.1016\/j.aohep.2025.102144_bib0015","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/CM9.0000000000002703","article-title":"Global trajectories of liver cancer burden from 1990 to 2019 and projection to 2035","volume":"136","author":"Yang","year":"2023","journal-title":"Chin Med J (Engl)"},{"issue":"5","key":"10.1016\/j.aohep.2025.102144_bib0016","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/cam4.4530","article-title":"The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels","volume":"11","author":"Yang","year":"2022","journal-title":"Cancer Med"},{"issue":"10440","key":"10.1016\/j.aohep.2025.102144_bib0017","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"10440","key":"10.1016\/j.aohep.2025.102144_bib0018","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Naghavi","year":"2024","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.aohep.2025.102144_bib0019","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2020.02.068","article-title":"Global burden of 5 major types of gastrointestinal cancer","volume":"159","author":"Arnold","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.aohep.2025.102144_bib0020","doi-asserted-by":"crossref","first-page":"371","DOI":"10.14218\/JCTH.2023.00455","article-title":"Mortality burden of liver cancer in China: an observational study from 2008 to 2020","volume":"12","author":"Liu","year":"2024","journal-title":"J Clin Transl Hepatol"},{"issue":"6317","key":"10.1016\/j.aohep.2025.102144_bib0021","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/350427a0","article-title":"Mutational hotspot in the p53 gene in human hepatocellular carcinomas","volume":"350","author":"Hsu","year":"1991","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.aohep.2025.102144_bib0022","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.ejca.2012.02.009","article-title":"Population attributable risk of aflatoxin-related liver cancer: systematic review and meta-analysis","volume":"48","author":"Liu","year":"2012","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.aohep.2025.102144_bib0023","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/liv.14843","article-title":"Epidemiological projections of viral-induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination","volume":"41","author":"Vo Quang","year":"2021","journal-title":"Liver Int"},{"issue":"10","key":"10.1016\/j.aohep.2025.102144_bib0024","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1158\/1940-6207.CAPR-13-0168","article-title":"Reduced aflatoxin exposure presages decline in liver cancer mortality in an endemic region of China","volume":"6","author":"Chen","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"issue":"2","key":"10.1016\/j.aohep.2025.102144_bib0025","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1386-6346(98)00119-3","article-title":"Prevalence of hepatitis C virus infection in the general population and patients with liver disease in China","volume":"14","author":"Xuezhong","year":"1999","journal-title":"Hepatol Res"},{"issue":"6","key":"10.1016\/j.aohep.2025.102144_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2024.106298","article-title":"Relative contribution of hepatitis B and C viruses in primary liver cancer in China: a systematic review and meta-analysis","volume":"89","author":"Wen","year":"2024","journal-title":"J Infect"},{"issue":"7","key":"10.1016\/j.aohep.2025.102144_bib0027","first-page":"984","article-title":"Gender differences in the pathogenesis and risk factors of hepatocellular carcinoma","volume":"12","author":"Nevola","year":"2023","journal-title":"Biol (Basel)"},{"key":"10.1016\/j.aohep.2025.102144_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1433540","article-title":"Exploiting gender-based biomarkers and drug targets: advancing personalized therapeutic strategies in hepatocellular carcinoma","volume":"15","author":"Su","year":"2024","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.aohep.2025.102144_bib0029","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.45525","article-title":"Trends in hepatocellular carcinoma mortality rates in the US and projections through 2040","volume":"7","author":"Qiu","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.aohep.2025.102144_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.iliver.2024.100113","article-title":"Unraveling the epidemiology of metabolic dysfunction-associated liver cancer: insights from mixed etiologies, regional variations, and gender disparities","volume":"3","author":"Feng","year":"2024","journal-title":"Iliver"},{"issue":"5","key":"10.1016\/j.aohep.2025.102144_bib0031","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.aohep.2025.102144_bib0032","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102144_bib0033","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.14324","article-title":"Global timing of hepatitis C virus elimination in high-income countries","volume":"40","author":"Razavi","year":"2020","journal-title":"Liver Int"},{"issue":"3","key":"10.1016\/j.aohep.2025.102144_bib0034","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.aohep.2025.102144_bib0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S2468-1253(18)30270-X","article-title":"Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission","volume":"4","author":"Cooke","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102144_bib0036","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3350\/cmh.2021.0193","article-title":"Cost-effectiveness of chronic hepatitis C screening and treatment","volume":"28","author":"Lee","year":"2022","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102144_bib0037","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1016\/S2214-109X(21)00517-9","article-title":"Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation","volume":"10","author":"Su","year":"2022","journal-title":"Lancet Glob Health"},{"issue":"14","key":"10.1016\/j.aohep.2025.102144_bib0038","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3748\/wjg.v28.i14.1405","article-title":"Viral hepatitis: past, present, and future","volume":"28","author":"Odenwald","year":"2022","journal-title":"World J Gastroenterol"},{"issue":"7","key":"10.1016\/j.aohep.2025.102144_bib0039","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/sj.bjc.6603649","article-title":"Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review","volume":"96","author":"Raza","year":"2007","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.aohep.2025.102144_bib0040","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.35106","article-title":"Relative importance of Hepatitis B and C viruses in hepatocellular carcinoma in EMRO countries and the Middle East: a systematic review","volume":"16","author":"Alavian","year":"2016","journal-title":"Hepat Mon"},{"issue":"2","key":"10.1016\/j.aohep.2025.102144_bib0041","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/ijc.30463","article-title":"Cancer incidence and cancer control in Mongolia: results from the National Cancer Registry 2008-12","volume":"140","author":"Chimed","year":"2017","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.aohep.2025.102144_bib0042","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5005\/jp-journals-10018-1215","article-title":"Viral Hepatitis and liver diseases in Mongolia","volume":"7","author":"Baatarkhuu","year":"2017","journal-title":"Euroasian J Hepatogastroenterol"},{"issue":"11","key":"10.1016\/j.aohep.2025.102144_bib0043","first-page":"975","article-title":"Chinese Clinical practice guidelines for the prevention and treatment of mother-to-child transmission of Hepatitis B virus (Version 2024)","volume":"12","author":"Liu","year":"2024","journal-title":"J Clin Transl Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2025.102144_bib0044","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2024.12.004","article-title":"The 2024 updated WHO guidelines for the prevention and management of chronic hepatitis B: main changes and potential implications for the next major liver society clinical practice guidelines","volume":"82","author":"Wong","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2025.102144_bib0045","article-title":"A community-based strategy to eliminate hepatitis C among people who inject drugs in Vietnam","volume":"37","author":"Nagot","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"10360","key":"10.1016\/j.aohep.2025.102144_bib0046","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.aohep.2025.102144_bib0047","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jhep.2021.02.029","article-title":"Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan","volume":"75","author":"Liao","year":"2021","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.aohep.2025.102144_bib0048","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global burden of disease Study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.aohep.2025.102144_bib0049","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a037069","article-title":"Hepatitis C virus: 30 years after its discovery","volume":"9","author":"Houghton","year":"2019","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"7","key":"10.1016\/j.aohep.2025.102144_bib0050","first-page":"646","article-title":"Real-world effectiveness and tolerability of interferon-free direct-acting antiviral for 15,849 patients with chronic Hepatitis C: a multinational cohort study","volume":"12","author":"Ji","year":"2024","journal-title":"J Clin Transl Hepatol"},{"issue":"12","key":"10.1016\/j.aohep.2025.102144_bib0051","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S2468-1253(20)30249-1","article-title":"Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis","volume":"5","author":"Tseng","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102144_bib0052","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.30823","article-title":"Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents","volume":"71","author":"Kanwal","year":"2020","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2025.102144_bib0053","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.aohep.2025.102144_bib0054","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.jhep.2021.01.046","article-title":"Antiviral therapy in the palliative setting of HCC (BCLC-B and -C)","volume":"74","author":"Reig","year":"2021","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.aohep.2025.102144_bib0055","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S1470-2045(22)00383-7","article-title":"Cabozantinib plus atezolizumab in advanced hepatocellular carcinoma and the role of adjuvant antiviral therapy","volume":"23","author":"Ji","year":"2022","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102144_bib0056","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/HEP.0000000000001026","article-title":"Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: the impact of successful antiviral treatment","volume":"81","author":"Celsa","year":"2025","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2025.102144_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7201a1","article-title":"Screening and testing for Hepatitis B Virus infection: CDC recommendations - United States, 2023","volume":"72","author":"Conners","year":"2023","journal-title":"MMWR Recomm Rep"},{"issue":"10042","key":"10.1016\/j.aohep.2025.102144_bib0058","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0140-6736(16)31144-8","article-title":"Towards elimination of viral hepatitis by 2030","volume":"388","author":"The","year":"2016","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.aohep.2025.102144_bib0059","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S2468-1253(20)30238-7","article-title":"The impact of COVID-19 on hepatitis elimination","volume":"5","author":"Wingrove","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.aohep.2025.102144_bib0060","article-title":"Impact of the COVID-19 pandemic on hepatitis B and C elimination: an EASL survey","volume":"4","author":"Kondili","year":"2022","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.aohep.2025.102144_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100685","article-title":"The impact of COVID-19 on the cascade of care of HCV in the US and China","volume":"27","author":"Yeo","year":"2022","journal-title":"Ann Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2025.102144_bib0062","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jhep.2022.07.028","article-title":"Impact of the COVID-19 pandemic on liver disease-related mortality rates in the United States","volume":"78","author":"Gao","year":"2023","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102144_bib0063","first-page":"751","article-title":"Trends of cirrhosis-related mortality in the USA during the COVID-19 Pandemic","volume":"11","author":"Yeo","year":"2023","journal-title":"J Clin Transl Hepatol"},{"issue":"8","key":"10.1016\/j.aohep.2025.102144_bib0064","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1136\/gutjnl-2022-328188","article-title":"Most excess years of potential life loss among individuals with cirrhosis during the pandemic were not related to COVID-19","volume":"72","author":"Zhao","year":"2023","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.aohep.2025.102144_bib0065","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1136\/gutjnl-2023-330271","article-title":"Temporal trend of mortality in patients with cirrhosis with primary biliary cholangitis and primary sclerosing cholangitis during the COVID-19 pandemic","volume":"73","author":"He","year":"2024","journal-title":"Gut"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:52:58Z","timestamp":1780649578000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125003692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1665268125003692"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102144","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends and health inequalities of hepatitis virus-associated liver cancer mortality during 1990\u20132050","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102144"}}